TALEN

TALEN2-foxp3a

ID
ZDB-TALEN-180628-4
Name
TALEN2-foxp3a
Previous Names
None
Target
Target Sequence 1
5' - CCTGGAGACAGAAGCATA - 3'
Target Sequence 2
5' - GCTGTACTCTGTCTTTCT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
um252 foxp3a
um253 foxp3a
Expression
Gene expression in Wild Types + TALEN2-foxp3a
No data available
Phenotype
Phenotype resulting from TALEN2-foxp3a
No data available
Phenotype of all Fish created by or utilizing TALEN2-foxp3a
Phenotype Fish Conditions Figures
posterior intestine ifng1 expression decreased amount, abnormal foxp3aum252/um252 standard conditions Fig. 5 with image from Kasheta et al., 2017
whole organism decreased life span, abnormal foxp3aum252/um252 standard conditions Fig. 4 from Kasheta et al., 2017
cloacal chamber inflammatory response increased occurrence, abnormal foxp3aum252/um252 standard conditions Fig. 5 with image from Kasheta et al., 2017
spleen increased size, abnormal foxp3aum252/um252 standard conditions Fig. 5 with image from Kasheta et al., 2017
head kidney lymphocyte increased amount, abnormal foxp3aum252/um252 standard conditions Fig. 5 with image from Kasheta et al., 2017
head kidney foxp3b expression decreased amount, abnormal foxp3aum252/um252 standard conditions Fig. 4 from Kasheta et al., 2017
integument ifng1 expression decreased amount, abnormal foxp3aum252/um252 standard conditions Fig. 5 with image from Kasheta et al., 2017
head kidney myeloid cell decreased amount, abnormal foxp3aum252/um252 standard conditions Fig. 5 with image from Kasheta et al., 2017
posterior intestine il1b expression decreased amount, abnormal foxp3aum252/um252 standard conditions Fig. 5 with image from Kasheta et al., 2017
whole organism decreased life span, abnormal foxp3aum253/um253 standard conditions Fig. 4 from Kasheta et al., 2017
head kidney lymphocyte increased amount, abnormal foxp3aum253/um253 standard conditions Fig. 5 with image from Kasheta et al., 2017
head kidney myeloid cell decreased amount, abnormal foxp3aum253/um253 standard conditions Fig. 5 with image from Kasheta et al., 2017
spleen lymphocyte increased amount, abnormal cz2Tg ; foxp3aum252/um252 standard conditions Fig. 5 with image from Kasheta et al., 2017
whole organism decreased life span, abnormal foxp3aum253/+ ; foxp3aum252/+ standard conditions Fig. 4 from Kasheta et al., 2017
head kidney lymphocyte increased amount, abnormal foxp3aum253/+ ; foxp3aum252/+ standard conditions Fig. 5 with image from Kasheta et al., 2017
head kidney myeloid cell decreased amount, abnormal foxp3aum253/+ ; foxp3aum252/+ standard conditions Fig. 5 with image from Kasheta et al., 2017
lymphocyte increased amount, abnormal foxp3aum252/um252 ; rag1hu1999/hu1999 standard conditions Fig. S3 with image from Kasheta et al., 2017
spleen increased size, abnormal foxp3aum252/um252 ; rag1hu1999/hu1999 standard conditions Fig. S3 with image from Kasheta et al., 2017
cloacal chamber inflammatory response occurrence, ameliorated foxp3aum252/um252 ; rag1hu1999/hu1999 standard conditions Fig. 5 with image from Kasheta et al., 2017
whole organism decreased size, abnormal foxp3aum252/um252 ; rag1hu1999/hu1999 standard conditions Fig. S3 with image from Kasheta et al., 2017
Citations